Literature DB >> 24011471

Bordetella bronchiseptica in a pediatric Cystic Fibrosis center.

Cynthia Brady1, Patricia Ackerman2, Mahrya Johnson2, John McNamara3.   

Abstract

BACKGROUND: Bordetella bronchiseptica is a common pathogenic or colonizing organism of domestic mammals. In dogs, it causes an infectious tracheobronchitis known as Kennel Cough. Human infections are unusual and almost exclusively described in immunocompromised patients who have had contact with a known animal reservoir. It is rarely reported in Cystic Fibrosis (CF), possibly hampered by low recovery from culture and organism misidentification. We describe the incidence and characteristics of B. bronchiseptica in our CF population.
METHODS: A retrospective cohort study was conducted of our center's CF patient population. Patients were included if they had B. bronchiseptica isolated on one or more occasion.
RESULTS: Seven children with CF isolated B. bronchiseptica on 23 occasions, frequently associated with the symptoms of a pulmonary exacerbation. Four patients required hospitalization.
CONCLUSION: These results suggest that B. bronchiseptica may be more common than previously reported and may play a potential pathogenic role in CF.
© 2013.

Entities:  

Keywords:  Animal; Bordetella bronchiseptica; Cystic Fibrosis; Pathogen

Mesh:

Substances:

Year:  2013        PMID: 24011471     DOI: 10.1016/j.jcf.2013.08.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

1.  Comparative analyses of a cystic fibrosis isolate of Bordetella bronchiseptica reveal differences in important pathogenic phenotypes.

Authors:  Neelima Sukumar; Tracy L Nicholson; Matt S Conover; Tridib Ganguly; Rajendar Deora
Journal:  Infect Immun       Date:  2014-01-27       Impact factor: 3.441

2.  Draft Genome Assembly of Bordetella bronchiseptica ATCC 10580, a Historical Canine Clinical Isolate.

Authors:  H E Daligault; K W Davenport; T D Minogue; K A Bishop-Lilly; D C Bruce; P S Chain; S R Coyne; K G Frey; J Jaissle; G I Koroleva; J T Ladner; C-C Lo; L Meincke; C Munk; G F Palacios; C L Redden; S L Johnson
Journal:  Genome Announc       Date:  2014-09-18

3.  Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.

Authors:  Laurence Pages-Monteiro; Romain Marti; Carine Commun; Nolwenn Alliot; Claire Bardel; Helene Meugnier; Michele Perouse-de-Montclos; Philippe Reix; Isabelle Durieu; Stephane Durupt; Francois Vandenesch; Jean Freney; Benoit Cournoyer; Anne Doleans-Jordheim
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

4.  Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection.

Authors:  Manlio Monti; Danila Diano; Francesco Allegrini; Angelo Delmonte; Valentina Fausti; Paola Cravero; Giulia Marcantognini; Giovanni Luca Frassineti
Journal:  BMC Infect Dis       Date:  2017-09-25       Impact factor: 3.090

5.  Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity.

Authors:  Andrea Hahn; Aszia Burrell; Hani Fanous; Hollis Chaney; Iman Sami; Geovanny F Perez; Anastassios C Koumbourlis; Robert J Freishtat; Keith A Crandall
Journal:  Heliyon       Date:  2018-09-17

6.  Bordetella bronchiseptica in non-cystic fibrosis bronchiectasis.

Authors:  Elham Karamooz; Vanessa L Yap; Alan F Barker; Mark L Metersky
Journal:  Respir Med Case Rep       Date:  2018-08-28

Review 7.  Conquering the host: Bordetella spp. and Pseudomonas aeruginosa molecular regulators in lung infection.

Authors:  Alina M Holban; Courtney M Gregoire; Monica C Gestal
Journal:  Front Microbiol       Date:  2022-09-26       Impact factor: 6.064

8.  Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections.

Authors:  R Darrah; T Bonfield; J J LiPuma; P Litman; C A Hodges; F Jacono; M Drumm
Journal:  J Infect Pulm Dis       Date:  2017-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.